288 related articles for article (PubMed ID: 22479405)
21. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
[TBL] [Abstract][Full Text] [Related]
22. Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function.
Desimmie BA; Smith JL; Matsuo H; Hu WS; Pathak VK
Retrovirology; 2017 Mar; 14(1):19. PubMed ID: 28302150
[TBL] [Abstract][Full Text] [Related]
23. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
Donahue JP; Vetter ML; Mukhtar NA; D'Aquila RT
Virology; 2008 Jul; 377(1):49-53. PubMed ID: 18499212
[TBL] [Abstract][Full Text] [Related]
24. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
[TBL] [Abstract][Full Text] [Related]
25. Vif-CBFβ interaction is essential for Vif-induced cell cycle arrest.
Du J; Rui Y; Zheng W; Li P; Kang J; Zhao K; Sun T; Yu XF
Biochem Biophys Res Commun; 2019 Apr; 511(4):910-915. PubMed ID: 30851937
[TBL] [Abstract][Full Text] [Related]
26. Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.
Gai Y; Duan S; Wang S; Liu K; Yu X; Yang C; Li G; Zhou Y; Yu B; Wu J; Wang C; Yu X
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675833
[TBL] [Abstract][Full Text] [Related]
27. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel Cullin5 binding domain in HIV-1 Vif.
Xiao Z; Xiong Y; Zhang W; Tan L; Ehrlich E; Guo D; Yu XF
J Mol Biol; 2007 Oct; 373(3):541-50. PubMed ID: 17869271
[TBL] [Abstract][Full Text] [Related]
29. Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
Duan S; Yu X; Wang C; Meng L; Gai Y; Zhou Y; Gu T; Yu B; Wu J; Yu X
J Virol; 2022 Sep; 96(17):e0055522. PubMed ID: 35950859
[TBL] [Abstract][Full Text] [Related]
30. Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation.
Knecht KM; Hu Y; Rubene D; Cook M; Ziegler SJ; Jónsson SR; Xiong Y
J Biol Chem; 2021; 296():100045. PubMed ID: 33465707
[TBL] [Abstract][Full Text] [Related]
31. Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.
Marcsisin SR; Engen JR
J Mol Biol; 2010 Oct; 402(5):892-904. PubMed ID: 20728451
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
[TBL] [Abstract][Full Text] [Related]
33. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly.
Stanley BJ; Ehrlich ES; Short L; Yu Y; Xiao Z; Yu XF; Xiong Y
J Virol; 2008 Sep; 82(17):8656-63. PubMed ID: 18562529
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3.
Evans SL; Schön A; Gao Q; Han X; Zhou X; Freire E; Yu XF
Retrovirology; 2014 Jan; 11():4. PubMed ID: 24422669
[TBL] [Abstract][Full Text] [Related]
35. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.
Hultquist JF; McDougle RM; Anderson BD; Harris RS
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1543-51. PubMed ID: 22725134
[TBL] [Abstract][Full Text] [Related]
36. ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.
Hüttenhain R; Xu J; Burton LA; Gordon DE; Hultquist JF; Johnson JR; Satkamp L; Hiatt J; Rhee DY; Baek K; Crosby DC; Frankel AD; Marson A; Harper JW; Alpi AF; Schulman BA; Gross JD; Krogan NJ
Cell Host Microbe; 2019 Jul; 26(1):86-99.e7. PubMed ID: 31253590
[TBL] [Abstract][Full Text] [Related]
37. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.
Luo K; Xiao Z; Ehrlich E; Yu Y; Liu B; Zheng S; Yu XF
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11444-9. PubMed ID: 16076960
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53.
Luo K; Ehrlich E; Xiao Z; Zhang W; Ketner G; Yu XF
FASEB J; 2007 Jun; 21(8):1742-50. PubMed ID: 17351129
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
[TBL] [Abstract][Full Text] [Related]
40. Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.
Zuo T; Liu D; Lv W; Wang X; Wang J; Lv M; Huang W; Wu J; Zhang H; Jin H; Zhang L; Kong W; Yu X
J Virol; 2012 May; 86(10):5497-507. PubMed ID: 22379088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]